García-Salguero Cristina, González-Corralejo Carlos, Marroyo Laso Jose, Delgado-Iribarren García-Campero Alberto
Departamento de Microbiología Clínica, Instituto de Medicina del Laboratorio (IML) e Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, España.
Departamento de Medicina, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Gut Pathog. 2025 Apr 11;17(1):22. doi: 10.1186/s13099-025-00697-1.
Arcobacter butzleri is a foodborne pathogen that has been positioned as an emerging cause of bacterial enteritis. It can affect any type of person although vulnerable people are more susceptible. In addition, resistance to several antibiotics has been described, which is a problem for antimicrobial empirical treatment and this makes it a threat to public health.Seven isolates of this pathogen were collected during 2024. Susceptibility studies were performed on first-line antibiotics for the treatment of gastroenteritis in our epidemiological environment. Resistance rates higher than 25% were observed for all antimicrobials tested, except erythromycin. Based on these data, it would be necessary to carry out a study of antimicrobial resistance profile of this microorganism for their treatment and control.
布氏弓形杆菌是一种食源性病原体，已被认定为细菌性肠炎的一个新发病因。它可感染任何类型的人，不过弱势群体更易感染。此外，已有关于该菌对多种抗生素耐药的报道，这给抗菌经验性治疗带来了问题，使其成为公共卫生的一大威胁。2024年期间收集了该病原体的七株分离株。针对我们流行病学环境中治疗肠胃炎的一线抗生素进行了药敏研究。除红霉素外，所有测试抗菌药物的耐药率均高于25%。基于这些数据，有必要针对该微生物的治疗和控制开展抗菌耐药谱研究。
